University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

Distribution of Medication Disposal Packets - Acute Opioid Prescribing

Not Applicable

Completed

Conditions: Orthopedic Surgery
Neurosurgery
Opioid Misuse
Opioid Use
Surgery

Interventions: Other: Medication Disposal Packet

First Posted Date: 2021-12-23

Last Posted Date: 2023-06-02

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 657

Registration Number: NCT05169281

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM

Phase 1

Recruiting

Conditions: Glioblastoma

Interventions: Drug: CART-EGFR-IL13Ra2 Cells

First Posted Date: 2021-12-23

Last Posted Date: 2024-12-24

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 18

Registration Number: NCT05168423

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Evaluation of Four Injectable Neuromodulators in the Glabella Area Glabella Area

Not Applicable

Completed

Conditions: Cosmetic Techniques

Interventions: Drug: Onabotulinumtoxina for Injection
Drug: Abobotulinumtoxina for Injection
Drug: IncobotulinumtoxinA for Injection
Drug: PrabotulinumtoxinA for Injection

First Posted Date: 2021-12-22

Last Posted Date: 2023-07-19

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 143

Registration Number: NCT05167864

Locations: 🇺🇸
Penn Medicine, Philadelphia, Pennsylvania, United States

Immune Profiles in Multiple Sclerosis (MS) Patients and Healthy Volunteers Through Thoracic Duct Cannulation

Not Applicable

Conditions: Multiple Sclerosis
Healthy

Interventions: Procedure: thoracic duct cannulation

First Posted Date: 2021-12-17

Last Posted Date: 2024-07-19

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 24

Registration Number: NCT05162638

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Peer Comparison Feedback to Providers to Improve Hypertension Control

Not Applicable

Active, not recruiting

Conditions: Hypertension

Interventions: Behavioral: Peer Comparison Message

First Posted Date: 2021-12-16

Last Posted Date: 2024-10-26

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 93

Registration Number: NCT05160012

Locations: 🇺🇸
Lancaster General Hospital, Lancaster, Pennsylvania, United States

Cerebral Hemodynamics and Microemboli During Placement of Relay®Branch Thoracic Stent-Graft System

Active, not recruiting

Conditions: Thoracic Aortic Aneurysm
Thoracic Aortic Dissection
Microemboli

First Posted Date: 2021-12-14

Last Posted Date: 2024-11-22

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 20

Registration Number: NCT05155956

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
Penn Presbyterian Medical Center, Philadelphia, Pennsylvania, United States

Pilot Study: Investigating Mood Changes After Slow-wave Enhancement

Not Applicable

Not yet recruiting

Conditions: Depression
Depression, Unipolar
Depressive Disorder, Major
Depressive Disorder

Interventions: Device: Sham device
Device: Slow-wave enhancement

First Posted Date: 2021-12-06

Last Posted Date: 2024-02-07

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 20

Registration Number: NCT05146427

SGLT2i and KNO3 in HFpEF - The SAK HFpEF Trial

Phase 2

Recruiting

Conditions: Heart Failure With Preserved Ejection Fraction

Interventions: Drug: Empagliflozin + Potassium Chloride
Drug: Empagliflozin + Potassium Nitrate
Drug: Potassium Chloride + Placebo for Empagliflozin

First Posted Date: 2021-12-01

Last Posted Date: 2024-06-27

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 53

Registration Number: NCT05138575

Locations: 🇺🇸
University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States

Promoting Recovery After STroke With Amantadine

Phase 2

Recruiting

Conditions: Stroke, Ischemic
Stroke Hemorrhagic

Interventions: Drug: Placebo
Drug: Amantadine

First Posted Date: 2021-12-01

Last Posted Date: 2024-02-21

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 60

Registration Number: NCT05140148

Locations: 🇺🇸
The Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Effectiveness and Mechanisms of Recovery Oriented Cognitive Therapy

Not Applicable

Withdrawn

Conditions: Schizophrenia
Schizoaffective Disorder

Interventions: Other: Treatment as Usual
Behavioral: Recovery Oriented Cognitive Therapy (CT-R)

First Posted Date: 2021-12-01

Last Posted Date: 2022-05-31

Lead Sponsor: University of Pennsylvania

Registration Number: NCT05140135

Locations: 🇺🇸
Eirini Zoupou, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy